CD34 and acute myeloid leukemia: We further stratified AML patients according to their therapeutic response and explored the relationship between mitochondrial ATPsyn-β expression and clinical stages both in BMMCs (mRNA assay: n = 110; western blot assay: n = 80) (Figure 5) and in CD34+ cells (n = 20) (Figure 6).